NCT00784394View on ClinicalTrials.gov

Diindolylmethane in Preventing Cancer in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Healthy, no Evidence of Disease
Interventions
DRUG

diindolylmethane

Given PO

OTHER

placebo

Given PO

OTHER

pharmacological study

Correlative studies

OTHER

laboratory biomarker analysis

Correlative studies

OTHER

quality-of-life assessment

Ancillary studies

Trial Locations (1)

66160

University of Kansas Medical Center, Kansas City

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00784394 - Diindolylmethane in Preventing Cancer in Healthy Volunteers | Biotech Hunter | Biotech Hunter